急诊科精神疾病患者的心血管结局差异
该回顾性队列纳入2010-2017年华盛顿州因未特指胸痛从急诊科出院成人的医疗补助受益者,共98,812次治疗后离院就诊。比较任何精神疾病、严重精神疾病与无精神疾病患者的心血管结局。30天MACE无差异(AOR 0.96;95% CI 0.72-1.27),但6个月任何精神疾病(AOR 1.86;95% CI 1.11-3.09)和严重精神疾病(AOR 2.60;95% CI 1.33-5.13)心血管住院风险更高;任何精神疾病30天检查率更高(AOR 1.16;95% CI 1.07-1.27)。提示胸痛急诊离院后精神疾病患者长期心血管住院和检查利用存在差异。
要点
- 因胸痛急诊治疗后离院的精神疾病患者,30天MACE与无精神疾病者无差异(AOR 0.96;95% CI 0.72-1.27)。
- 6个月心血管住院风险:任何精神疾病AOR 1.86(95% CI 1.11-3.09),严重精神疾病AOR 2.60(95% CI 1.33-5.13)。
- 任何精神疾病患者30天心血管诊断检查率更高(AOR 1.16;95% CI 1.07-1.27)。
- 研究纳入98,812次治疗后离院急诊就诊,为回顾性队列,仅限华盛顿州成年医疗补助受益者。
适用人群与场景
- 2010-2017年华盛顿州成年医疗补助受益者,因未特指胸痛主要诊断从急诊科出院,仅纳入治疗后离院就诊。
- 任何精神疾病定义:索引急诊就诊前1年内有任何精神健康诊断或使用精神健康专项服务。
- 严重精神疾病定义:索引急诊就诊前1年内至少两次(不同服务日期)索赔记录有精神分裂症、其他精神病性障碍或重性心境障碍诊断。
诊断标准与关键阈值
- MACE定义:出院后30天和6个月内死亡、急性心肌梗死、心血管再住院或血运重建的复合终点。
- 次要结局:急诊出院后30天内心血管诊断检查率(诊断性血管造影、负荷试验、超声心动图、冠状动脉CT血管造影)。
研究设计与关键结果
- 研究设计:回顾性队列,纳入98,812次治疗后离院急诊就诊,比较任何精神疾病、严重精神疾病与无精神疾病患者的心血管结局。
- 30天MACE:任何精神疾病与无精神疾病相比无差异(AOR 0.96;95% CI 0.72-1.27),各单一组分亦无差异。
- 6个月心血管住院:任何精神疾病AOR 1.86(95% CI 1.11-3.09),严重精神疾病AOR 2.60(95% CI 1.33-5.13),均高于无精神疾病者。
- 30天心血管诊断检查:任何精神疾病检查率更高(AOR 1.16;95% CI 1.07-1.27)。
- 模型控制年龄、性别、种族、民族、Elixhauser合并症、过去一年医疗服务使用及固定年份效应。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 因胸痛从急诊治疗后离院的精神疾病患者,30天内MACE风险与无精神疾病者相似,但6个月内心血管住院风险更高。
- 任何精神疾病患者30天心血管诊断检查率更高,提示对该人群的检查利用存在差异。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Patients with mental illness have been shown to receive lower quality of care and experience worse cardiovascular (CV) outcomes compared to those without mental illness. This present study examined mental health-related disparities in CV outcomes after an Emergency Department (ED) visit for chest pain.
METHODS: This retrospective cohort included adult Medicaid beneficiaries in Washington state discharged from the ED with a primary diagnosis of unspecified chest pain in 2010-2017. Outcomes for patients with any mental illness (any mental health diagnosis or mental-health specific service use within 1 year of an index ED visit) and serious mental illness (at least two claims (on different dates of service) within 1 year of an index ED visit with a diagnosis of schizophrenia, other psychotic disorder, or major mood disorder) were compared to those of patients without mental illness. Our outcomes of interest were the incidence of major adverse cardiac events (MACE) within 30 days and 6 months of discharge of their ED visit, defined as a composite of death, acute myocardial infarction (AMI), CV rehospitalization, or revascularization. Secondary outcomes included cardiovascular diagnostic testing (diagnostic angiography, stress testing, echocardiography, and coronary computed tomography (CT) angiography) rates within 30 days of ED discharge. Only treat-and-release visits were included for outcomes assessment. Hierarchical logistic random effects regression models assessed the association between mental illness and the outcomes of interest, controlling for age, gender, race, ethnicity, Elixhauser comorbidities, and health care use in the past year, as well as fixed year effects.
RESULTS: There were 98,812 treat-and-release ED visits in our dataset. At 30 days, enrollees with any mental illness had no differences in rates of MACE (AOR 0.96; 95% CI, 0.72-1.27) or any of the individual components. At 6 months, enrollees with any mental illness (AOR 1.86; 95% CI, 1.11-3.09) and serious mental illness (AOR 2.60; 95% CI 1.33-5.13) were significantly more likely to be hospitalized for a CV condition compared to those without mental illness. Individuals with any mental illness had higher rates of testing at 30 days (AOR 1.16; 95% CI 1.07-1.27).
CONCLUSION: Patients with mental illness have similar rates of MACE, but higher rates of certain CV outcomes, such as CV hospitalization and diagnostic testing, after an ED visit for chest pain.
参考来源
- Kumar S, Duber HC, Kreuter W, et al. Disparities in cardiovascular outcomes among emergency department patients with mental illness. Am J Emerg Med. 2022. PMID: 35279577. doi:10.1016/j.ajem.2022.02.037
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。